Thrombotic adverse events associated with TNF-alpha blockers: a real-world pharmacovigilance analysis of the FAERS database
This study suggests that TNF - α blockers are associated with various adverse events of thrombosis, with different risks in different patient groups and treatment stages. Clinical doctors should assess individual thrombosis risk and closely monitor coagulation related indicators when using TNF - α inhibitors. This study offers valuable insights for optimizing treatment and improving safety.
Authors
- Jingkai Di (ORCID: https://orcid.org/0000-0002-2814-9400)
- Lijuan Song (ORCID: https://orcid.org/0000-0003-2945-5669)
- Nan Yang (ORCID: https://orcid.org/0000-0003-4237-4513)
- Xinglong Xing
- Yicong Zhao (ORCID: https://orcid.org/0009-0008-1738-8335)
Institutions
- Shanxi Medical University (CN)
- Second Hospital of Shanxi Medical University (CN)
- Shanxi Academy of Medical Sciences (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-04-25
- DOI
- https://doi.org/10.3389/fphar.2025.1512806
- Citations
- 2
- Primary Topic
- Heparin-Induced Thrombocytopenia and Thrombosis
- Type
- article
- Field-Weighted Citation Impact
- 4.01